Display options
Cite
Nichols SP, Schoenfisch MH. Nitric oxide-flux dependent bacterial adhesion and viability at fibrinogen-coated surfaces. Biomater Sci. 2013;1(11)doi: 10.1039/C3BM60130G.
Nichols, S. P., & Schoenfisch, M. H. (2013). Nitric oxide-flux dependent bacterial adhesion and viability at fibrinogen-coated surfaces. Biomaterials science, 1(11), . https://doi.org/10.1039/C3BM60130G
Nichols, Scott P, and Schoenfisch, Mark H. "Nitric oxide-flux dependent bacterial adhesion and viability at fibrinogen-coated surfaces." Biomaterials science vol. 1,11 (2013). doi: https://doi.org/10.1039/C3BM60130G
Nichols SP, Schoenfisch MH. Nitric oxide-flux dependent bacterial adhesion and viability at fibrinogen-coated surfaces. Biomater Sci. 2013 Nov 01;1(11). doi: 10.1039/C3BM60130G. PMID: 24288588; PMCID: PMC3839865.
Copy Download .nbib Format: NLM
Share it on

Biomater Sci. 2013 Nov 01;1(11). doi: 10.1039/C3BM60130G.

Nitric oxide-flux dependent bacterial adhesion and viability at fibrinogen-coated surfaces.

Biomaterials science

Scott P Nichols, Mark H Schoenfisch

Affiliations

  1. Department of Chemistry, Caudill Laboratories, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.

PMID: 24288588 PMCID: PMC3839865 DOI: 10.1039/C3BM60130G

Abstract

Nitric oxide (NO) is an endogenous antibacterial agent produced by immune cells in response to pathogens. Herein, the NO fluxes necessary to reduce bacterial adhesion of different bacteria (

References

  1. J Control Release. 2000 Jan 3;63(1-2):175-89 - PubMed
  2. Chem Soc Rev. 2012 May 21;41(10):3753-8 - PubMed
  3. Biomaterials. 2009 Oct;30(29):5675-81 - PubMed
  4. Appl Microbiol Biotechnol. 2010 Sep;88(2):401-7 - PubMed
  5. J Biomed Mater Res A. 2003 Dec 15;67(4):1276-83 - PubMed
  6. Eur J Biochem. 1997 Jul 1;247(1):416-24 - PubMed
  7. J Bacteriol. 1916 May;1(3):321-31 - PubMed
  8. J Clin Invest. 1997 Jun 15;99(12):2818-25 - PubMed
  9. Chem Soc Rev. 2006 Sep;35(9):780-9 - PubMed
  10. Chem Soc Rev. 2012 May 21;41(10):3731-41 - PubMed
  11. Sci Transl Med. 2012 Sep 26;4(153):153rv10 - PubMed
  12. Mol Pharm. 2010 Dec 6;7(6):2289-96 - PubMed
  13. Int J Antimicrob Agents. 2009 Aug;34(2):103-10 - PubMed
  14. Ann Intern Med. 2000 Mar 7;132(5):391-402 - PubMed
  15. Clin Microbiol Infect. 2002 May;8(5):256-64 - PubMed
  16. J Biomed Mater Res. 2000 May;50(2):160-70 - PubMed
  17. J Microbiol Methods. 2011 Aug;86(2):238-42 - PubMed
  18. Infect Immun. 1998 Jun;66(6):2666-73 - PubMed
  19. Science. 2008 Mar 21;319(5870):1672-6 - PubMed
  20. Biomaterials. 1997 Jun;18(12):839-44 - PubMed
  21. Free Radic Biol Med. 1998 Sep;25(4-5):434-56 - PubMed
  22. Biomaterials. 2005 Jul;26(21):4405-15 - PubMed
  23. Chem Soc Rev. 2012 May 21;41(10):3742-52 - PubMed
  24. J Biol Chem. 2001 Jul 27;276(30):27799-805 - PubMed
  25. Eur Cell Mater. 2004 Dec 07;8:37-57 - PubMed
  26. Biomaterials. 2005 Dec;26(34):6984-90 - PubMed
  27. Biomacromolecules. 2012 Oct 8;13(10):3334-42 - PubMed
  28. Biomaterials. 2008 Oct;29(30):4039-44 - PubMed
  29. Biomaterials. 2009 Sep;30(27):4494-502 - PubMed
  30. Biomacromolecules. 2004 Sep-Oct;5(5):2034-41 - PubMed
  31. Biomaterials. 2005 Mar;26(8):917-24 - PubMed
  32. Microbiology (Reading). 1997 Jul;143 ( Pt 7):2407-2413 - PubMed
  33. J Clin Microbiol. 1999 Jun;37(6):1771-6 - PubMed
  34. Biomaterials. 2007 Apr;28(11):1948-56 - PubMed
  35. J Orthop Trauma. 2011 Jul;25(7):432-7 - PubMed
  36. J Intensive Care Med. 2010 May-Jun;25(3):131-8 - PubMed
  37. J Am Chem Soc. 2001 Oct 3;123(39):9712-3 - PubMed
  38. Proc Am Thorac Soc. 2006 Apr;3(2):161-5 - PubMed

Publication Types

Grant support